EMD SERONO, INC. lobbying for EMD SERONO INC

Filing 2nd Quarter - Report

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 21, 2025

Expenses

$910,000.00

What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Government bodies contacted 6

Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Health & Human Services, Dept of (HHS)
HOUSE OF REPRESENTATIVES
SENATE
White House Office

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 10

HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
HR 946
ORPHAN Cures Act
HR 2214
DRUG Act
S 864
HELP Copays Act
S 882
Patients Before Middlemen Act
S 891
Bipartisan Health Care Act
S 1862
ORPHAN Cures Act
HR 1492
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic can…
S 832
EPIC Act of 2025
HR 220
Veterans Infertility Treatment Act of 2025

Lobbying activity 9

Health Issues

H.R. 1: One Big Beautiful Bill Act; provisions related to Title VII, Subtitle B H.R. 946: Orphan CURES Act; all provisions H.R. 2214: DRUG Act; all provisions S. 864: HELP Copays Act; all provisions S. 882: Patients Before Middlemen Act; all provisions S. 891: Bipartisan Health Care Act; provisions related to Titles I, II, VIII, and IX S. 1862: Orphan CURES Act; all provisions Executive Order: Expanding Access to In Vitro Fertilization; all provisions of the order General discussions related to Pharmacy Benefit Manager policy issues General discussions related to Healthcare supply chain policy issues General discussions related to Drug cost and pricing policy issues General discussions related to caregiving support and awareness policy issues

Medicare/Medicaid

H.R. 1: One Big Beautiful Bill Act; relating to Title VII, Subtitle B H.R. 1492: To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.; all provisions S. 832: EPIC Act of 2025; all provisions S. 891: Bipartisan Health Care Act; provisions related to Titles I, II, VIII, and IX General discussions related to Drug cost and pricing policy issues

Pharmacy

General discussions related to Drug cost and pricing policy issues General discussions related to Healthcare supply chain policy issues General discussions related to 340B Drug Pricing Program policy issues

Taxation/Internal Revenue Code

H.R. 1: One Big Beautiful Bill Act; provisions related to Sec. 899

Veterans

H.R. 220: Veterans Infertility Treatment Act of 2025; all provisions

Defense

Discussions related to Military access to infertility care

Copyright/Patent/Trademark

General discussions related to Biopharmaceutical innovation and patent policy issues

Trade (domestic/foreign)

Discussions related to tariffs

Environment/Superfund

Discussions related to the Environmental Protection Agency's (EPA) Low Volume Exemption (LVE) Process